PLASMA LEVEL OF DES-ACYL GHRELIN PREDICTS DIGESTIVE SYMPTOMS IN PATIENTS UNDERGOING CHEMOTHERAPY FOR ADVANCED PANCREATIC CANCER

被引：0
|
作者：
Miura, T. [1 ,3 ]
Mitsunaga, S. [1 ,2 ]
Matsumoto, N. [4 ]
Nakazato, M. [4 ]
Ohno, I. [1 ]
Shimizu, S. [1 ]
Takahashi, H. [1 ]
Okuyama, H. [1 ]
Kuwahara, A. [1 ]
Ikeda, M. [1 ]
机构：
[1] Natl Canc Ctr Hosp E, Div Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp E, Dept Palliat Care & Psychooncol, Kashiwa, Chiba, Japan
[4] Miyazaki Univ, Fac Med, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, Miyazaki, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [41] Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy
    Yu, Shu-Lin
    Xu, Li-Tao
    Qi, Qi
    Geng, Ya-Wen
    Chen, Hao
    Meng, Zhi-Qiang
    Wang, Peng
    Chen, Zhen
    SCIENTIFIC REPORTS, 2017, 7
  • [42] Multimodal Exercise in Older Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy: A Case Series Examining Feasibility and Preliminary Efficacy
    Luo, Hao
    Galvao, Daniel A.
    Newton, Robert U.
    Tang, Colin I.
    Spry, Nigel
    Taaffe, Dennis R.
    EUROPEAN JOURNAL OF CANCER CARE, 2023, 2023
  • [43] Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors
    Tsutsumi, Hirono
    Inoue, Hiroyuki
    Shiraishi, Yoshimasa
    Hirayama, Aiko
    Nakanishi, Takayuki
    Ando, Hiroyuki
    Nakajima, Maako
    Shinozaki, Seiji
    Ogata, Hiroaki
    Okamura, Koji
    Kimura, Shinichi
    Ogawa, Tomohiro
    Ota, Keiichi
    Yoneshima, Yasuto
    Tanaka, Kentaro
    Hamada, Naoki
    Okamoto, Isamu
    Iwama, Eiji
    LUNG CANCER, 2023, 181
  • [44] Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
    Jung, Hae Hyun
    Kim, Ji-Yeon
    Cho, Eun Yoon
    Oh, Jung Min
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCERS, 2021, 13 (21)
  • [45] Dynamics of KRAS G12/13 allele burden in circulating tumor DNA predicts survival in patients with unresectable pancreatic cancer undergoing palliative chemotherapy
    Johansen, J. S.
    Vibat, C. R. T.
    Hancock, S.
    Chen, I.
    Samuelsz, E.
    Collisson, E. A.
    Jensen, B. V.
    Melnikova, V.
    Erlander, M. G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S470 - S471
  • [46] Effects of Traditional Chinese Medicine "Fuzheng Qingdu Decoction" on Autonomic Function and Cancer-Related Symptoms in Patients with Advanced Gastric Cancer undergoing Chemotherapy: A Controlled Trial
    Yuan, Chengjia
    Wu, Shuang
    Wu, Yang
    Tian, Cuiling
    Wang, Zaichuan
    Zhang, Xiaochun
    INTEGRATIVE CANCER THERAPIES, 2024, 23
  • [47] Weekly gemcitabine and cisplatin chemotherapy:: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients.: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
    Cascinu, S
    Labianca, R
    Catalano, V
    Barni, S
    Ferraù, F
    Beretta, GD
    Frontini, L
    Foa, P
    Pancera, G
    Priolo, D
    Graziano, F
    Mare, M
    Catalano, G
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 205 - 208
  • [48] Pretreatment Albumin-to-Fibrinogen Ratio Independently Predicts Chemotherapy Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Total Mesorectal Excision After Neoadjuvant Chemoradiotherapy
    Li, Hongzhi
    Wang, Honggang
    Shao, Shanshan
    Gu, Yawen
    Yao, Juan
    Huang, Junxing
    ONCOTARGETS AND THERAPY, 2020, 13 : 13121 - 13130
  • [49] Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy
    L.-P. Ge
    J. Li
    Q.-L. Bao
    P. Chen
    Q. Jiang
    L.-R. Zhu
    Clinical and Translational Oncology, 2015, 17 : 57 - 64
  • [50] Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy
    Ge, L. -P.
    Li, J.
    Bao, Q. -L.
    Chen, P.
    Jiang, Q.
    Zhu, L. -R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (01): : 57 - 64
12345